Hillevax
Aditya Kohli is a Co-Founder and Chief Business Officer at HilleVax and has multiple titles within the company, including CBO, Board Director, and COO. Aditya also holds the title of Venture Partner at Frazier Life Sciences. With a background in bioengineering, Aditya has co-founded several successful companies in the pharmaceutical and biotech industries, including Phathom Pharmaceuticals, Passage Bio, and Recida Therapeutics. Aditya has also held positions at McKinsey & Company and Scout Bio, where Aditya served as a Board Director and Co-founder.
This person is not in any offices
Hillevax
2 followers
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Their initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.